Novel antiparasitic compounds for Chagas disease and Leishmaniasis

Novel antiparasitic compounds for Chagas disease and Leishmaniasis

Novel antiparasitic compounds for Chagas disease and Leishmaniasis

Novel antiparasitic compounds  for Chagas disease and Leishmaniasis

Universitat de València and Universidad de Granada have developed novel compounds for the treatment of Chagas' disease and Leishmaniasis. These new compounds show higher antiparasitic activity and are ten times less toxic than drugs in use.

INDUSTRIAL PROPERTY RIGHTS

The technology is protected through the following patents:

Spanish patent application P201132035, titled "Compuestos macrocíclicos de tipo escorpiando y su uso como antiparasitarios". PCT extension number PCT/ES2012/070866.

FURTHER INFORMATION
Industry environment: Health Promotion and Efficient Health
Entity: Universitat de València (UV)

CONTACT:

Oficina de Transferència de Resultats d'Investigació (OTRI)
Universitat de València


One To One